Product information

Current status:

Cancelled Post Market

Current status date:

2001-08-01

Original market date: ^{See footnote 1}

1999-01-21

Product name:

VARIVAX

DIN:

02239199 Electronic product monograph is not available

Company:

MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO.
16711 Trans Canada Highway
Kirkland
Quebec
Canada H9H 3L1

Class:

Human

Dosage form(s):

Powder For Solution

Route(s) of administration:

Subcutaneous

Number of active ingredient(s):

1

Schedule(s):

Schedule D

American Hospital Formulary Service (AHFS): ^{See footnote 3}

80:12.00 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

J07BK01 VARICELLA, LIVE ATTENUATED

Active ingredient group (AIG) number:^{See footnote5}

0152480001